Literature DB >> 18481951

Cytokine signalling in the beta-cell: a dual role for IFNgamma.

Conny Gysemans1, Hanne Callewaert, Lutgart Overbergh, Chantal Mathieu.   

Abstract

IFNgamma (interferon gamma), a cytokine typically secreted by infiltrating immune cells in insulitis in Type 1 diabetes, is by itself not detrimental to beta-cells, but, together with other cytokines, such as IL-1beta (interleukin 1beta) and TNFalpha (tumour necrosis factor alpha), or dsRNA (double-stranded RNA), it induces beta-cell apoptosis. The complex gene and protein networks that are altered by the combination of cytokines clearly point towards synergisms between these agents. IFNgamma acts mostly via JAK (Janus kinase) activation, with the transcription factors STAT-1 (signal transducer and activator of transcription-1) and IRF-1 (IFNgamma regulatory factor-1) playing a central role in the downstream pathway. The study of mice with a disruption of these transcription factors has revealed a possible dual role for IFNgamma in beta-cell destruction by cytokines or dsRNA. We demonstrated that the absence of STAT-1 from beta-cells completely protects against IFNgamma+IL-1beta- and IFNgamma+dsRNA-mediated beta-cell death in vitro, whereas absence of IRF-1 does not prevent cytokine-induced beta-cell apoptosis. In vivo, a lack of the IRF-1 gene in pancreatic islets even promotes low-dose streptozotocin-induced diabetes, whereas lack of STAT-1 confers resistance against beta-cell death following low-dose streptozotocin-induced diabetes. Additionally, IRF-1(-/-) islets are more sensitive to PNF (primary islet non-function) after transplantation in spontaneously diabetic NOD (non-obese diabetic) mice, whereas STAT-1(-/-) islets are fully protected. Moreover, proteomic analysis of beta-cells exposed to IFNgamma or IFNgamma+IL-1beta confirms that very different pathways are activated by IFNgamma alone compared with the combination. We conclude that IFNgamma may play a dual role in immune-induced beta-cell destruction. Transcription factors drive this dual role, with STAT-1 driving beta-cell destruction and IRF-1 possibly playing a role in up-regulation of protective pathways induced by IFNgamma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18481951     DOI: 10.1042/BST0360328

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  21 in total

1.  STAT1 is a master regulator of pancreatic {beta}-cell apoptosis and islet inflammation.

Authors:  Fabrice Moore; Najib Naamane; Maikel L Colli; Thomas Bouckenooghe; Fernanda Ortis; Esteban N Gurzov; Mariana Igoillo-Esteve; Chantal Mathieu; Gianluca Bontempi; Thomas Thykjaer; Torben F Ørntoft; Decio L Eizirik
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

2.  Interferon-γ inhibits central nervous system myelination through both STAT1-dependent and STAT1-independent pathways.

Authors:  Wensheng Lin; Yifeng Lin
Journal:  J Neurosci Res       Date:  2010-09       Impact factor: 4.164

Review 3.  Innate immunity and heat shock response in islet transplantation.

Authors:  Y Lai; C Chen; T Linn
Journal:  Clin Exp Immunol       Date:  2009-02-04       Impact factor: 4.330

4.  Early differences in islets from prediabetic NOD mice: combined microarray and proteomic analysis.

Authors:  Inne Crèvecoeur; Valborg Gudmundsdottir; Saurabh Vig; Fernanda Marques Câmara Sodré; Wannes D'Hertog; Ana Carolina Fierro; Leentje Van Lommel; Conny Gysemans; Kathleen Marchal; Etienne Waelkens; Frans Schuit; Søren Brunak; Lut Overbergh; Chantal Mathieu
Journal:  Diabetologia       Date:  2017-01-12       Impact factor: 10.122

5.  SET7/9 Enzyme Regulates Cytokine-induced Expression of Inducible Nitric-oxide Synthase through Methylation of Lysine 4 at Histone 3 in the Islet β Cell.

Authors:  Kyoko Fujimaki; Takeshi Ogihara; David L Morris; Hisanobu Oda; Hitoshi Iida; Yoshio Fujitani; Raghavendra G Mirmira; Carmella Evans-Molina; Hirotaka Watada
Journal:  J Biol Chem       Date:  2015-05-20       Impact factor: 5.157

Review 6.  The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes.

Authors:  James W Ramadan; Stephen R Steiner; Christina M O'Neill; Craig S Nunemaker
Journal:  Cell Calcium       Date:  2011-09-23       Impact factor: 6.817

7.  Plasma levels of 14:0, 16:0, 16:1n-7, and 20:3n-6 are positively associated, but 18:0 and 18:2n-6 are inversely associated with markers of inflammation in young healthy adults.

Authors:  Maude Perreault; Kaitlin Roke; Alaa Badawi; Daiva E Nielsen; Salma A Abdelmagid; Ahmed El-Sohemy; David W L Ma; David M Mutch
Journal:  Lipids       Date:  2013-12-15       Impact factor: 1.880

Review 8.  RNA interference for improving the outcome of islet transplantation.

Authors:  Feng Li; Ram I Mahato
Journal:  Adv Drug Deliv Rev       Date:  2010-12-13       Impact factor: 15.470

9.  Influence of signal transducer and activator of transcription-1 signaling on thyroid morphology and function.

Authors:  Hiroaki J Kimura; Roberto Rocchi; Melissa A Landek-Salgado; Koichi Suzuki; Cindy Y Chen; Miho Kimura; Noel R Rose; Patrizio Caturegli
Journal:  Endocrinology       Date:  2009-03-26       Impact factor: 4.736

10.  Association between type 1, type 2 cytokines, diabetic autoantibodies and 25-hydroxyvitamin D in children with type 1 diabetes.

Authors:  I M Talaat; A Nasr; A A Alsulaimani; H Alghamdi; K A Alswat; D M Almalki; A Abushouk; A M Saleh; G Allam
Journal:  J Endocrinol Invest       Date:  2016-08-19       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.